Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis

By sjmartinez • April 6, 2023

Ballav S, Bhosale M, Lokhande KB, Paul MK, Padhye S, Swamy KV, Ranjan A, Basu S. Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis. Adv Biol (Weinh). 2023 Apr 5:e2300036. doi: 10.1002/adbi.202300036. Epub ahead of print. PMID: 37017501.

Tags: EMT, Lung cancer, Partial agonist, PPAR-γ, Publications, Pulmonary, Critical Care & Sleep Medicine, Quercetin derivatives, Schiff base

Related Posts

Sleep apnea in individuals with spinal cord injury

Sankari A, Aldwaikat A, Habra M, Salloum A, Zeineddine S, Pandya N, Martin JL, Badr MS. Sleep apnea in individuals with spinal cord injury. J[...]

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands

Nerguizian D, Wei Z, Aldrovandi G, Currier J, Eron J, Fischer W, Gandhi R, Hamill M, Hosey L, Javan A, McCarthy C, Nachman S, Valiyaparambil[...]

Efficacy and safety of bridging intravenous thrombolysis before mechanical thrombectomy: A systematic review and meta-analysis

Hashmi TM, Ahmed M, Ashraf H, Shakir M, Bhatti IA, Alareed A, Ahmed F, Hasan A, Ahmed R, Aized MT, Rafiq S, Fonarow GC, Hassan[...]